3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
9
Squamous Cell Carcinoma of Head and Neck
4
Nasopharyngeal Carcinoma
4
Esophageal Squamous Cell Carcinoma
4
Carcinoma, Non-Small-Cell Lung
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Esophageal Neoplasms
3
Pancreatic Neoplasms
2
Locally Advanced Rectal Cancer
2
Colonic Neoplasms
2
Cervical Cancer Metastatic
2
Breast Neoplasms
2
Adenocarcinoma
2
Turcot syndrome
1
Salivary Gland Neoplasms
1
Recurrence
1
Rectal Cancer Patients
1
Non-squamous Non-small-cell Lung Cancer
1
Mouth Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Laryngeal Neoplasms
1
Gestational Trophoblastic Disease
1
Esophageal Squamour Cell Cancer
1
Endometrioid Endometrial Cancer
1
Colorectal Neoplasms
1
Biliary Tract Neoplasms
1
Advanced Primary Liver Cancer
1
Interventions
Carboplatin
5
pembrolizumab
4
Paclitaxel
3
selpercatinib
2
durvalumab
2
Pemetrexed
2
Cisplatin
2
taletrectinib
1
repotrectinib
1
pralsetinib
1
pegylated granulocyte colony-stimulating factor
1
efineptakin alfa
1
ceralasertib
1
cemiplimab
1
atezolizumab
1
Telescopes
1
Radiosurgery
1
Nivolumab
1
Magnetic Resonance Imaging
1
Kyphoplasty
1
Injections, Epidural
1
Gemcitabine
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thoracic Neoplasms
×
camrelizumab
×
1 year
×
Clear all
No trials found.